- Oral iron therapy for anemia refers to the administration of iron supplements in oral form to treat iron deficiency anemia and other related conditions. These therapies are widely used due to their convenience, affordability, and effectiveness in replenishing iron stores in the body
- The global oral iron therapy market is experiencing significant growth, driven by the rising prevalence of anemia, particularly among pregnant women, children, and individuals with chronic diseases
- In addition, increasing awareness about iron deficiency and the availability of advanced formulations with better absorption and fewer gastrointestinal side effects are contributing to market expansion
- The market is further supported by government initiatives and nutrition programs aimed at addressing anemia worldwide
- For instance, in October 2023, the World Health Organization (WHO) launched a global campaign to reduce anemia prevalence through enhanced dietary interventions and supplementation programs. Moreover, pharmaceutical companies are focusing on innovative drug formulations, such as liposomal iron and polysaccharide iron complexes, to improve patient compliance
- Despite these advancements, challenges such as side effects, poor adherence, and competition from intravenous iron therapies remain. However, ongoing research and the development of novel drug delivery methods are expected to enhance the efficacy of oral iron therapies, driving future market growth
